Status:
RECRUITING
Smart Wearable Device (gaitQ): Walk Better Project
Lead Sponsor:
University of Exeter
Collaborating Sponsors:
GaitQ company
Conditions:
Parkinson Disease
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
This study will be underpinned by the new MRC guidelines for developing a complex intervention with a participatory design methodology that uses evidence-based research and behaviour change models alo...
Detailed Description
Detailed Description: Mobility issues affect 1/3 of the adult population requiring rehabilitation. Current shortages in skilled rehabilitation professionals require novel approaches to address this u...
Eligibility Criteria
Inclusion
- Eligibility Criteria This research will investigate the impact of the gaitQ product on a sufficiently large cohort of PwP, healthy controls and other potential conditions such as stroke and hip and knee replacements.
- Inclusion criteria
- Participants with long-term conditions affecting movement
- Diagnosis of idiopathic Parkinson's disease (UK Brain Bank Criteria) or other appropriate condition-specific scales \[stroke, multiple sclerosis, arthritis or osteoporosis\]
- Able to self-report history of daily gait freezing and/or festination for people with PD or gait affected by condition
- Able to walk unsupported or using an aid for at least 3 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carry out this level of exercise
- Adult (+18 years old)
- Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support
- Montreal Cognitive assessment score \>21 or ability to follow 2-stage commands
- Healthy participants
- With no long-term conditions affecting movement
- Able to walk unsupported or using an aid for at least 3 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise
- Adult (+18 years old)
- Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support
Exclusion
- Montreal Cognitive assessment score \>21 or ability to follow 2 stage commands 7.1.2 Exclusion criteria
- Participants with long-term conditions affecting movement
- Any physical or mental condition affecting the ability to safely participate in this level of activity and capacity to understand testing as demonstrated by ability to safely follow commands and pass the PARQ by the research team.
- Cognitive impairment affecting the ability to safely participate and follow instructions
- Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition)
- Any skin conditions or broken skin in the calf and behind the knee area
- Deep brain stimulation or pacemaker implants or other implants that may interfere with the measurement system
- Healthy participants
- Any physical or mental condition affecting the ability to safely participate in this level of activity and capacity to understand testing as demonstrated by the ability to safely follow commands and pass the PARQ by the research team.
- Cognitive impairment affecting the ability to safely participate and follow instructions
- Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition)
- Any skin conditions or broken skin in the calf and behind the knee area
- Deep brain stimulation or pacemaker implants or other implants that may interfere with the measurement system
Key Trial Info
Start Date :
September 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05913219
Start Date
September 15 2023
End Date
February 28 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Exeter
Exeter, United Kingdom, EX1 2LU